请输入您要查询的百科知识:

 

词条 Brian Druker
释义

  1. Education

  2. Teaching and research

  3. Awards

  4. Personal

  5. References

  6. External links

{{Infobox scientist
| name = Brian J. Druker
| image = Druker Brian.jpg
| image_size =
| alt =
| caption =
| birth_date = {{Birth date and age|1955|4|30|mf=yes}}
| birth_place =
| death_date =
| death_place =
| residence =
| citizenship =
| nationality = American
| fields =
| workplaces = Howard Hughes Medical Institute, Oregon Health & Science University
| alma_mater = University of California, San Diego
| doctoral_advisor =
| academic_advisors =
| doctoral_students =
| notable_students =
| known_for = Gleevec
| author_abbrev_bot =
| author_abbrev_zoo =
| influences =
| influenced =
| awards = {{no wrap|Robert Koch Prize (2005)
Keio Medical Science Prize {{small|(2007)}}
Meyenburg Award {{small|(2009)}}
Lasker Clinical Award {{small|(2009)}}
Japan Prize {{small|(2012)}}
Dickson Prize (2012)
Albany Medical Center Prize (2013)}}
Sheikh Hamdan bin Rashid Al Maktoum Award for Medical Sciences {{small|(2013-14)}}
Tang Prize {{small|(2018)}}
The Sjöberg Prize {{small|(2019)}}
| signature =
| signature_alt =
| footnotes =
| spouse =
}}Brian J. Druker (born April 30, 1955)[1] is a physician-scientist at Oregon Health & Science University, in Portland, Oregon. He is the director of OHSU's Knight Cancer Institute,[2] Jeld-Wen Chair of Leukemia Research, and professor of medicine. In 2009, he won the Lasker-DeBakey Clinical Medical Research Award[3][4] and the Meyenburg Award[1] for his influential work in the development of Imatinib (or STI571), commonly known as Gleevec, for the treatment of chronic myeloid leukemia (CML).[1] He has been called "Oregon's best-known scientist".[5]

Education

Druker earned both his B.S. degree in chemistry and M.D. degree from the University of California, San Diego.[6] He completed internship and residency in internal medicine at Barnes Hospital, Washington University School of Medicine in St. Louis from 1981 to 1984.

Teaching and research

{{expand section|date=December 2015}}

Druker was a fellow in medical oncology at Dana–Farber Cancer Institute, Harvard Medical School, from 1984 to 1987. He began working at Oregon Health & Science University (OHSU) in 1993.[7]

In May 2007, he became director of the OHSU Cancer Institute—renamed the Knight Cancer Institute in October 2008 following a $100 million donation from Nike co-founder Phil Knight.[8]

Druker has been widely recognized for his work in developing the cancer-fighting drug commonly known as Gleevec,[7] but has been publicly critical of the drug's high price for patients.[9]

Awards

Druker is an investigator of Howard Hughes Medical Institute (HHMI),[7] and was elected to the Institute of Medicine of National Academies in 2003, the American Association of Physicians in 2006, and the National Academy of Sciences in 2007. In addition to the Lasker and Meyenburg awards, he was presented the Hope Funds Award of Excellence for Clinical Research in 2009.

In 2011, the American Society for Clinical Investigation presented Druker with its Stanley J. Korsmeyer Award in recognition of his advances in cancer research.[10] In 2014, he received the Hamdan Award for Medical Research Excellence (Targeted therapy category) and in 2018 the Tang Prize.

Personal

Druker is married to Alexandra Hardy, a one-time reporter for People magazine, and the couple have three children (as of 2009).[4] An earlier marriage, to Barbara Rodriguez in 1990, ended in divorce in 1999.[6]

References

1. ^{{cite web|title=Meyenburg Award 2009 for the First Targeted Anti-Cancer Drug|date=October 12, 2009|publisher=German Cancer Research Center|url=http://www.dkfz.de/en/presse/pressemitteilungen/2009/dkfz_pm_09_46.php |accessdate=2015-12-27}}
2. ^{{cite news|last=Terry|first=Lynne|title=OHSU's $1 billion war on cancer|url=http://www.oregonlive.com/health/index.ssf/2015/12/ohsu_hopes_1_billion_means_few.html|accessdate=2015-12-27|newspaper=The Oregonian|location=Portland, Oregon|date=December 20, 2015|orig-year=online date December 17|pages=A1, A12–A13}}
3. ^{{cite web|last=Strauss|first=Evelyn|title=2009 Winners: Lasker~DeBakey Clinical Medical Research Award |url=http://www.laskerfoundation.org/awards/2009_c_description.htm|publisher=Lasker Foundation|accessdate=2015-12-27}}
4. ^{{cite news|last=Dreifus|first=Claudia|authorlink=Claudia Dreifus|title=A conversation with: Researcher Behind the Drug Gleevec|url=https://www.nytimes.com/2009/11/03/science/03conv.html|accessdate=2015-12-27|newspaper=The New York Times|date=November 2, 2009}}
5. ^{{cite news|author=WW Staff|title=How OHSU's Brian Druker Hopes to Cure Cancer|url=http://www.wweek.com/portland/blog-31124-how_ohsus_brian_druker_hopes_to_cure_cancer.html|accessdate=2015-12-27|newspaper=Willamette Week|location=Portland, Oregon|date=January 16, 2014}}
6. ^{{cite news|last1=Charles|first1=Nick|title=The Miracle Worker: Dr. Brian Druker Fires a Magic Bullet That May Eliminate a Lethal Form of Leukemia|url=http://www.people.com/people/archive/article/0,,20133687,00.html|accessdate=2015-12-27|work=People|date=February 19, 2001}}
7. ^{{cite press release|title=Five to receive honorary degrees at 149th Commencement|url=http://news.wustl.edu/news/Pages/20707.aspx|publisher=Washington University in St. Louis|accessdate=2015-12-27|date=May 6, 2010}}
8. ^{{cite news|last=Dworkin|first=Andy|title=OHSU Cancer Institute gets $100 million donation|url=http://www.oregonlive.com/news/index.ssf/2008/10/knights_to_give_record_100_mil.html|accessdate=2015-12-27|newspaper=The Oregonian|location=Portland, Oregon|date=October 29, 2008}}
9. ^{{cite news|last=Budnick|first=Nick|title=Top Oregon Health & Science University researcher to doctors: Rise up over drug prices|url=http://www.oregonlive.com/health/index.ssf/2013/04/top_oregon_health_science_univ.html|accessdate=2015-12-27|newspaper=The Oregonian|location=Portland, Oregon|date=April 25, 2013}}
10. ^{{cite news|last1=Williams|first1=Elisa|title=OHSU's Druker recognized for pioneering cancer research|url=http://blog.oregonlive.com/higher-education/2011/02/ohsus_druker_recognized_for_pi.html|accessdate=2015-12-27|work=OregonLive.com|date=February 22, 2011}}

External links

  • [https://www.ibiology.org/human-disease/imatinib-paradigm-targeted-cancer-therapies/ Brian Druker Seminars: "Imatinib as a Paradigm of Targeted Cancer Therapies"]
{{Authority control}}{{DEFAULTSORT:Druker, Brian}}

12 : 1955 births|American hematologists|Members of the United States National Academy of Sciences|American oncologists|Oregon Health & Science University faculty|University of California, San Diego alumni|Living people|Howard Hughes Medical Investigators|Fellows of the American Academy of Arts and Sciences|Recipients of the Lasker-DeBakey Clinical Medical Research Award|Physicians from Portland, Oregon|Tang Prize laureates

随便看

 

开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。

 

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间:2024/11/15 21:17:08